PATENT CLAIM ANALYSIS

Application Number: 15951968
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["424", "472000"]

Abstract:
This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.

Claim (Index 57):
The pharmaceutical composition of  claim 53 , wherein the solabegron is an amorphous solid form of solabegron.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.61364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14958610', '15332956', '15868582', '11889962', '15323685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7019645821571808
- 35 USC 102 Novelty (BERT): 0.535488761356514
- Combined Prediction Score: 0.6853170000771142
- Mean Citation Score: 230.02221
- Max Citation Score: 345.05142
- Similarity Product: 251.88904454804785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test